Estefany Ingrid Medina Reyes

Dr. Estefany Ingrid Medina Reyes

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
EREstefany Ingrid Medina Reyes
Estefany Ingrid Medina Reyes
CRCarolina Rodríguez-Ibarra
Carolina Rodríguez-Ibarra
ADAlejandro Déciga-Alcaraz
Alejandro Déciga-Alcaraz
DDDaniel Díaz-Urbina
Daniel Díaz-Urbina
YCYolanda I. Chirino
Yolanda I. Chirino
JPJosé Pedraza-Chaverri
José Pedraza-Chaverri

1 April 2020 in Toxicology Letters
Verified
Journal Article
Closed access
CRCarolina Rodríguez-Ibarra
Carolina Rodríguez-Ibarra
ADAlejandro Déciga-Alcaraz
Alejandro Déciga-Alcaraz
OIOctavio Ispanixtlahuatl-Meráz
Octavio Ispanixtlahuatl-Meráz
EREstefany Ingrid Medina Reyes
Estefany Ingrid Medina Reyes
NDNorma L. Delgado-Buenrostro
Norma L. Delgado-Buenrostro
YCYolanda Irasema Chirino
Yolanda Irasema Chirino

1 January 2017 in Critical Reviews™ in Therapeutic Drug Carrier Systems
Verified
Journal Article
Closed access
PDF file
EREstefany Ingrid Medina Reyes
Estefany Ingrid Medina Reyes
DGDanae Garcia-Viacobo
Danae Garcia-Viacobo
FMFranklin A. Carrero- Martinez
Franklin A. Carrero- Martinez
YCYolanda Irasema Chirino
Yolanda Irasema Chirino
Recent advances in nanotechnology have transformed the biomedicine field, in which the use of engineered nanomaterials (ENMs) has provided the foundation for novel applications. For this reason, the number of ENMs has increased rapidly, and here we provide a classification of ENMs based on chemical composition and biomedical applications, which include regenerative medicine, delivery systems, theranostics, and therapy. These have been identified as the most advanced and promising areas for further studies with humans. In addition, we discuss possible side effects related to ENM uses. We identify carbon, metal, and metal oxides as the most versatile ENM material groups, used in bone and neuronal regenerative medicine, thermal therapy, theranostics, drug delivery, gene therapy, and biosensors. However, the majority of drugs approved by the U.S. Food and Drug Administration (FDA) are lipid-based ENMs. We conclude that biomedical applications of ENMs offer potential benefits while side effects are mainly associated with occupational exposure. Finally, we suggest that in the future, nanocomposites, subnanometric structures, and biodegradable and biocorona formation could be used to improve the biomedical field by focusing on infectious diseases, early detection, and precision medicine.

1 December 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
EREstefany Ingrid Medina Reyes
Estefany Ingrid Medina Reyes
NDNorma L. Delgado-Buenrostro
Norma L. Delgado-Buenrostro
DDDaniel Díaz-Urbina
Daniel Díaz-Urbina
CRCarolina Rodríguez-Ibarra
Carolina Rodríguez-Ibarra
ADAlejandro Déciga-Alcaraz
Alejandro Déciga-Alcaraz
JPJosé Pedraza-Chaverri
José Pedraza-Chaverri

1 June 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
EREstefany Ingrid Medina Reyes
Estefany Ingrid Medina Reyes
NDNorma L. Delgado-Buenrostro
Norma L. Delgado-Buenrostro
DLDaan L. Leseman
Daan L. Leseman
ADAlejandro Déciga-Alcaraz
Alejandro Déciga-Alcaraz
RHRuiwen He
Ruiwen He
YCYolanda I. Chirino
Yolanda I. Chirino

1 January 2015 in Environmental Research
Verified
Journal Article
Closed access
EREstefany Ingrid Medina Reyes
Estefany Ingrid Medina Reyes
ADAlejandro Déciga-Alcaraz
Alejandro Déciga-Alcaraz
VFVerónica Freyre-Fonseca
Verónica Freyre-Fonseca
NDNorma L. Delgado-Buenrostro
Norma L. Delgado-Buenrostro
JFJosé O. Flores-Flores
José O. Flores-Flores
YCYolanda Irasema Chirino
Yolanda Irasema Chirino